欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/1942/001
药品名称Cluvot 250
活性成分
    • blood coagulation factor XIII human 250.0 U
剂型Powder and solvent for solution for infusion
上市许可持有人CSL Behring GmbH Emil-von-Behring-Str. 76 35041 Marburg
参考成员国 - 产品名称Germany (DE)
Cluvot 250
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Cluvot® 250 IE Poeder en oplosmiddel voor oplossing voor injectie/infusie
    • Netherlands (NL)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      CLUVOT
    • Sweden (SE)
    • Norway (NO)
      Cluvot
    • Finland (FI)
    • Poland (PL)
      Cluvot 250
    • Luxembourg (LU)
    • Hungary (HU)
      CLUVOT 250 NE por és oldószer oldatos injekcióhoz vagy infúzióhoz
    • Bulgaria (BG)
    • Romania (RO)
      Cluvot® 250 pulbere si solvent pentru solutie injectabila
    • Malta (MT)
许可日期2014/02/11
最近更新日期2024/04/10
药物ATC编码
    • B02BD07 coagulation factor XIII
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Blood Product
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase